Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Sensitisation of TRPV4 by PAR2 is independent of intracellular calcium signalling and can be mediated by the biased agonist neutrophil elastase.
Sostegni S
,
Diakov A
,
McIntyre P
,
Bunnett N
,
Korbmacher C
,
Haerteis S
.
???displayArticle.abstract???
Proteolytic activation of protease-activated receptor 2 (PAR2) may represent a major mechanism of regulating the transient receptor potential vanilloid 4 (TRPV4) non-selective cation channel in pathophysiological conditions associated with protease activation (e.g. during inflammation). To provide electrophysiological evidence for PAR2-mediated TRPV4 regulation, we characterised the properties of human TRPV4 heterologously expressed in Xenopus laevis oocytes in the presence and absence of co-expressed human PAR2. In outside-out patches from TRPV4 expressing oocytes, we detected single-channel activity typical for TRPV4 with a single-channel conductance of about 100 pS for outward and 55 pS for inward currents. The synthetic TRPV4 activator GSK1016790A stimulated TRPV4 mainly by converting previously silent channels into active channels with an open probability of nearly one. In oocytes co-expressing TRPV4 and PAR2, PAR2 activation by trypsin or by specific PAR2 agonist SLIGRL-NH2 potentiated the GSK1016790A-stimulated TRPV4 whole-cell currents several fold, indicative of channel sensitisation. Pre-incubation of oocytes with the calcium chelator 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA)-AM did not reduce the stimulatory effect of PAR2 activation on TRPV4, which indicates that the effect is independent of intracellular calcium signalling. Neutrophil elastase, a biased agonist of PAR2 that does not induce intracellular calcium signalling, also caused a PAR2-dependent sensitisation of TRPV4. The Rho-kinase inhibitor Y27362 abolished elastase-stimulated sensitisation of TRPV4, which indicates that Rho-kinase signalling plays a critical role in PAR2-mediated TRPV4 sensitisation by the biased agonist neutrophil elastase. During acute inflammation, neutrophil elastase may sensitise TRPV4 by a mechanism involving biased agonism of PAR2 and activation of Rho-kinase.
Adebamiro,
A segment of gamma ENaC mediates elastase activation of Na+ transport.
2007, Pubmed
Adebamiro,
A segment of gamma ENaC mediates elastase activation of Na+ transport.
2007,
Pubmed
Barish,
A transient calcium-dependent chloride current in the immature Xenopus oocyte.
1983,
Pubmed
,
Xenbase
Brierley,
Selective role for TRPV4 ion channels in visceral sensory pathways.
2008,
Pubmed
Böhm,
Mechanisms of desensitization and resensitization of proteinase-activated receptor-2.
1996,
Pubmed
Camerer,
Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa.
2000,
Pubmed
,
Xenbase
Cenac,
Transient receptor potential vanilloid-4 has a major role in visceral hypersensitivity symptoms.
2008,
Pubmed
Chen,
Proteinase-activated receptor 2 sensitizes transient receptor potential vanilloid 1, transient receptor potential vanilloid 4, and transient receptor potential ankyrin 1 in paclitaxel-induced neuropathic pain.
2011,
Pubmed
Chen,
Temporomandibular joint pain: a critical role for Trpv4 in the trigeminal ganglion.
2013,
Pubmed
Chraïbi,
Protease modulation of the activity of the epithelial sodium channel expressed in Xenopus oocytes.
1998,
Pubmed
,
Xenbase
Corvera,
Mast cell tryptase regulates rat colonic myocytes through proteinase-activated receptor 2.
1997,
Pubmed
Cottrell,
Trypsin IV, a novel agonist of protease-activated receptors 2 and 4.
2004,
Pubmed
DeFea,
beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2.
2000,
Pubmed
Deng,
Scapuloperoneal spinal muscular atrophy and CMT2C are allelic disorders caused by alterations in TRPV4.
2010,
Pubmed
Diakov,
A novel pathway of epithelial sodium channel activation involves a serum- and glucocorticoid-inducible kinase consensus motif in the C terminus of the channel's alpha-subunit.
2004,
Pubmed
,
Xenbase
Diakov,
Cleavage in the {gamma}-subunit of the epithelial sodium channel (ENaC) plays an important role in the proteolytic activation of near-silent channels.
2008,
Pubmed
,
Xenbase
Dulon,
Proteinase-activated receptor-2 and human lung epithelial cells: disarming by neutrophil serine proteinases.
2003,
Pubmed
Durieux,
Trypsin induces Ca(2+)-activated Cl- currents in X. laevis oocytes.
1994,
Pubmed
,
Xenbase
Döring,
The role of neutrophil elastase in chronic inflammation.
1994,
Pubmed
Everaerts,
The vanilloid transient receptor potential channel TRPV4: from structure to disease.
2010,
Pubmed
Everaerts,
Inhibition of the cation channel TRPV4 improves bladder function in mice and rats with cyclophosphamide-induced cystitis.
2010,
Pubmed
Ferguson,
Phosphatidic acid and lysophosphatidic acid stimulate receptor-regulated membrane currents in the Xenopus laevis oocyte.
1992,
Pubmed
,
Xenbase
Gradilone,
Activation of Trpv4 reduces the hyperproliferative phenotype of cystic cholangiocytes from an animal model of ARPKD.
2010,
Pubmed
Grant,
Protease-activated receptor 2 sensitizes the transient receptor potential vanilloid 4 ion channel to cause mechanical hyperalgesia in mice.
2007,
Pubmed
Haerteis,
Plasmin and chymotrypsin have distinct preferences for channel activating cleavage sites in the γ subunit of the human epithelial sodium channel.
2012,
Pubmed
,
Xenbase
Haerteis,
Proteolytic activation of the epithelial sodium channel (ENaC) by the cysteine protease cathepsin-S.
2012,
Pubmed
,
Xenbase
Hansen,
A major role for proteolytic activity and proteinase-activated receptor-2 in the pathogenesis of infectious colitis.
2005,
Pubmed
Harris,
A novel neutrophil elastase inhibitor prevents elastase activation and surface cleavage of the epithelial sodium channel expressed in Xenopus laevis oocytes.
2007,
Pubmed
,
Xenbase
Hollenberg,
Biased signalling and proteinase-activated receptors (PARs): targeting inflammatory disease.
2014,
Pubmed
Jin,
Determinants of TRPV4 activity following selective activation by small molecule agonist GSK1016790A.
2011,
Pubmed
Kassmann,
Transient receptor potential vanilloid 1 (TRPV1), TRPV4, and the kidney.
2013,
Pubmed
Knecht,
Trypsin IV or mesotrypsin and p23 cleave protease-activated receptors 1 and 2 to induce inflammation and hyperalgesia.
2007,
Pubmed
Korbmacher,
A calcium-activated and nucleotide-sensitive nonselective cation channel in M-1 mouse cortical collecting duct cells.
1995,
Pubmed
Krueger,
Cholesterol depletion of the plasma membrane prevents activation of the epithelial sodium channel (ENaC) by SGK1.
2009,
Pubmed
,
Xenbase
Lamandé,
Mutations in TRPV4 cause an inherited arthropathy of hands and feet.
2011,
Pubmed
Landouré,
Mutations in TRPV4 cause Charcot-Marie-Tooth disease type 2C.
2010,
Pubmed
Leddy,
Follistatin in chondrocytes: the link between TRPV4 channelopathies and skeletal malformations.
2014,
Pubmed
Li,
TRPV4-mediated calcium influx into human bronchial epithelia upon exposure to diesel exhaust particles.
2011,
Pubmed
Liedtke,
TRPV4 as osmosensor: a transgenic approach.
2005,
Pubmed
Liedtke,
Vanilloid receptor-related osmotically activated channel (VR-OAC), a candidate vertebrate osmoreceptor.
2000,
Pubmed
Lohman,
Antagonism of protease-activated receptor 2 protects against experimental colitis.
2012,
Pubmed
Loukin,
Forward genetic analysis reveals multiple gating mechanisms of TRPV4.
2010,
Pubmed
,
Xenbase
Ma,
Electrophysiological properties of heteromeric TRPV4-C1 channels.
2011,
Pubmed
Mize,
Prostate-specific kallikreins-2 and -4 enhance the proliferation of DU-145 prostate cancer cells through protease-activated receptors-1 and -2.
2008,
Pubmed
Molino,
Interactions of mast cell tryptase with thrombin receptors and PAR-2.
1997,
Pubmed
Moore,
UVB radiation generates sunburn pain and affects skin by activating epidermal TRPV4 ion channels and triggering endothelin-1 signaling.
2013,
Pubmed
Nilius,
TRP channels: a TR(I)P through a world of multifunctional cation channels.
2005,
Pubmed
Nilius,
TRP channels in disease.
2007,
Pubmed
Nilius,
The puzzle of TRPV4 channelopathies.
2013,
Pubmed
Nystedt,
Molecular cloning of a potential proteinase activated receptor.
1994,
Pubmed
,
Xenbase
Oikonomopoulou,
Proteinase-activated receptors, targets for kallikrein signaling.
2006,
Pubmed
Ossovskaya,
Protease-activated receptors: contribution to physiology and disease.
2004,
Pubmed
Phan,
Functional characterization of TRPV4 as an osmotically sensitive ion channel in porcine articular chondrocytes.
2009,
Pubmed
Poole,
Protease-activated receptor 2 (PAR2) protein and transient receptor potential vanilloid 4 (TRPV4) protein coupling is required for sustained inflammatory signaling.
2013,
Pubmed
Raisinghani,
Activation characteristics of transient receptor potential ankyrin 1 and its role in nociception.
2011,
Pubmed
,
Xenbase
Ramachandran,
Agonist-biased signaling via proteinase activated receptor-2: differential activation of calcium and mitogen-activated protein kinase pathways.
2009,
Pubmed
Ramachandran,
Neutrophil elastase acts as a biased agonist for proteinase-activated receptor-2 (PAR2).
2011,
Pubmed
Ramsay,
Kallikrein-related peptidase 4 (KLK4) initiates intracellular signaling via protease-activated receptors (PARs). KLK4 and PAR-2 are co-expressed during prostate cancer progression.
2008,
Pubmed
Ramsay,
Prostatic trypsin-like kallikrein-related peptidases (KLKs) and other prostate-expressed tryptic proteinases as regulators of signalling via proteinase-activated receptors (PARs).
2008,
Pubmed
Rauh,
A mutation of the epithelial sodium channel associated with atypical cystic fibrosis increases channel open probability and reduces Na+ self inhibition.
2010,
Pubmed
,
Xenbase
Rock,
Gain-of-function mutations in TRPV4 cause autosomal dominant brachyolmia.
2008,
Pubmed
Sipe,
Transient receptor potential vanilloid 4 mediates protease activated receptor 2-induced sensitization of colonic afferent nerves and visceral hyperalgesia.
2008,
Pubmed
Smith,
Evidence for the activation of PAR-2 by the sperm protease, acrosin: expression of the receptor on oocytes.
2000,
Pubmed
Sostegni,
Erratum to: Sensitisation of TRPV4 by PAR2 is independent of intracellular calcium signalling and can be mediated by the biased agonist neutrophil elastase.
2017,
Pubmed
Suen,
Modulating human proteinase activated receptor 2 with a novel antagonist (GB88) and agonist (GB110).
2012,
Pubmed
Sullivan,
Optical recording reveals novel properties of GSK1016790A-induced vanilloid transient receptor potential channel TRPV4 activity in primary human endothelial cells.
2012,
Pubmed
Takeuchi,
Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates.
2000,
Pubmed
,
Xenbase
Thorneloe,
N-((1S)-1-{[4-((2S)-2-{[(2,4-dichlorophenyl)sulfonyl]amino}-3-hydroxypropanoyl)-1-piperazinyl]carbonyl}-3-methylbutyl)-1-benzothiophene-2-carboxamide (GSK1016790A), a novel and potent transient receptor potential vanilloid 4 channel agonist induces urinary bladder contraction and hyperactivity: Part I.
2008,
Pubmed
Vergnolle,
TRPV4: new therapeutic target for inflammatory bowel diseases.
2014,
Pubmed
Vergnolle,
Protease-activated receptors in inflammation, neuronal signaling and pain.
2001,
Pubmed
Vincent,
Identification and characterization of novel TRPV4 modulators.
2009,
Pubmed
,
Xenbase
Voets,
The principle of temperature-dependent gating in cold- and heat-sensitive TRP channels.
2004,
Pubmed
Vriens,
Cell swelling, heat, and chemical agonists use distinct pathways for the activation of the cation channel TRPV4.
2004,
Pubmed
Watanabe,
Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels.
2003,
Pubmed
Watanabe,
Heat-evoked activation of TRPV4 channels in a HEK293 cell expression system and in native mouse aorta endothelial cells.
2002,
Pubmed
Watanabe,
Activation of TRPV4 channels (hVRL-2/mTRP12) by phorbol derivatives.
2002,
Pubmed
Watanabe,
Modulation of TRPV4 gating by intra- and extracellular Ca2+.
2003,
Pubmed
Wilson,
The membrane-anchored serine protease, TMPRSS2, activates PAR-2 in prostate cancer cells.
2005,
Pubmed
Ye,
TRPV4 is a regulator of adipose oxidative metabolism, inflammation, and energy homeostasis.
2012,
Pubmed
de Boer,
Protease-activated receptor-2 deficient mice have reduced house dust mite-evoked allergic lung inflammation.
2014,
Pubmed
